183 related articles for article (PubMed ID: 36476508)
1. Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors.
Kang M; Na HY; Ahn S; Kim JW; Lee S; Ahn S; Lee JH; Youk J; Kim HT; Kim KJ; Suh KJ; Lee JS; Kim SH; Kim JW; Kim YJ; Lee KW; Yoon YS; Kim JH; Chung JH; Han HS; Lee JS
Elife; 2022 Dec; 11():. PubMed ID: 36476508
[TBL] [Abstract][Full Text] [Related]
2. Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer.
Lin J; Peng X; Dong K; Long J; Guo X; Li H; Bai Y; Yang X; Wang D; Lu X; Mao Y; Sang X; Ji X; Zhao H; Liang H
Nat Commun; 2021 Aug; 12(1):4753. PubMed ID: 34362903
[TBL] [Abstract][Full Text] [Related]
3. Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination.
Lawrence-Paul MR; Pan TC; Pant DK; Shih NNC; Chen Y; Belka GK; Feldman M; DeMichele A; Chodosh LA
Genome Med; 2024 Feb; 16(1):26. PubMed ID: 38321573
[TBL] [Abstract][Full Text] [Related]
4. The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
Savas P; Teo ZL; Lefevre C; Flensburg C; Caramia F; Alsop K; Mansour M; Francis PA; Thorne HA; Silva MJ; Kanu N; Dietzen M; Rowan A; Kschischo M; Fox S; Bowtell DD; Dawson SJ; Speed TP; Swanton C; Loi S
PLoS Med; 2016 Dec; 13(12):e1002204. PubMed ID: 28027312
[TBL] [Abstract][Full Text] [Related]
5. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
[TBL] [Abstract][Full Text] [Related]
6. Subclonal diversification of primary breast cancer revealed by multiregion sequencing.
Yates LR; Gerstung M; Knappskog S; Desmedt C; Gundem G; Van Loo P; Aas T; Alexandrov LB; Larsimont D; Davies H; Li Y; Ju YS; Ramakrishna M; Haugland HK; Lilleng PK; Nik-Zainal S; McLaren S; Butler A; Martin S; Glodzik D; Menzies A; Raine K; Hinton J; Jones D; Mudie LJ; Jiang B; Vincent D; Greene-Colozzi A; Adnet PY; Fatima A; Maetens M; Ignatiadis M; Stratton MR; Sotiriou C; Richardson AL; Lønning PE; Wedge DC; Campbell PJ
Nat Med; 2015 Jul; 21(7):751-9. PubMed ID: 26099045
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Clonal Evolution in Microsatellite Unstable Metastatic Cancers through Multiregional Tumor Sequencing.
Bonneville R; Paruchuri A; Wing MR; Krook MA; Reeser JW; Chen HZ; Dao T; Samorodnitsky E; Smith AM; Yu L; Nowacki N; Chen W; Roychowdhury S
Mol Cancer Res; 2021 Mar; 19(3):465-474. PubMed ID: 33229401
[TBL] [Abstract][Full Text] [Related]
8. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.
Kim TM; Jung SH; An CH; Lee SH; Baek IP; Kim MS; Park SW; Rhee JK; Lee SH; Chung YJ
Clin Cancer Res; 2015 Oct; 21(19):4461-72. PubMed ID: 25979483
[TBL] [Abstract][Full Text] [Related]
9. Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma.
Liu B; Mitani Y; Rao X; Zafereo M; Zhang J; Zhang J; Futreal PA; Lozano G; El-Naggar AK
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117356
[TBL] [Abstract][Full Text] [Related]
10. Mutational landscape of paired primary and synchronous metastatic lymph node in chemotherapy naive gallbladder cancer.
Fan B; Xu X; Wang X
Mol Biol Rep; 2022 Feb; 49(2):1295-1301. PubMed ID: 34988893
[TBL] [Abstract][Full Text] [Related]
11. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
[TBL] [Abstract][Full Text] [Related]
12. Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers.
Cho SY; Chae J; Na D; Kang W; Lee A; Min S; Kang J; Choi B; Lee J; Sung CO; Chuang JH; Lee C; Lee WS; Park H; Kim JI
Clin Cancer Res; 2019 May; 25(9):2821-2834. PubMed ID: 30670495
[TBL] [Abstract][Full Text] [Related]
13. Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors.
Goswami RS; Patel KP; Singh RR; Meric-Bernstam F; Kopetz ES; Subbiah V; Alvarez RH; Davies MA; Jabbar KJ; Roy-Chowdhuri S; Lazar AJ; Medeiros LJ; Broaddus RR; Luthra R; Routbort MJ
Clin Cancer Res; 2015 Jun; 21(11):2644-51. PubMed ID: 25695693
[TBL] [Abstract][Full Text] [Related]
14. Evolution and Impact of Subclonal Mutations in Papillary Thyroid Cancer.
Masoodi T; Siraj AK; Siraj S; Azam S; Qadri Z; Parvathareddy SK; Al-Sobhi SS; AlDawish M; Alkuraya FS; Al-Kuraya KS
Am J Hum Genet; 2019 Nov; 105(5):959-973. PubMed ID: 31668701
[TBL] [Abstract][Full Text] [Related]
15. A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.
Amin NA; Seymour E; Saiya-Cork K; Parkin B; Shedden K; Malek SN
Clin Cancer Res; 2016 Sep; 22(17):4525-35. PubMed ID: 27060156
[TBL] [Abstract][Full Text] [Related]
16. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
[TBL] [Abstract][Full Text] [Related]
17. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes.
Nepal C; Zhu B; O'Rourke CJ; Bhatt DK; Lee D; Song L; Wang D; Van Dyke AL; Choo-Wosoba H; Liu Z; Hildesheim A; Goldstein AM; Dean M; LaFuente-Barquero J; Lawrence S; Mutreja K; Olanich ME; Lorenzo Bermejo J; ; Ferreccio C; Roa JC; Rashid A; Hsing AW; Gao YT; Chanock SJ; Araya JC; Andersen JB; Koshiol J
J Hepatol; 2021 May; 74(5):1132-1144. PubMed ID: 33276026
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.
Nadeu F; Delgado J; Royo C; Baumann T; Stankovic T; Pinyol M; Jares P; Navarro A; Martín-García D; Beà S; Salaverria I; Oldreive C; Aymerich M; Suárez-Cisneros H; Rozman M; Villamor N; Colomer D; López-Guillermo A; González M; Alcoceba M; Terol MJ; Colado E; Puente XS; López-Otín C; Enjuanes A; Campo E
Blood; 2016 Apr; 127(17):2122-30. PubMed ID: 26837699
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Analyses of Mutational Subclonal Architecture and Tumor Subtypes in Recurrent Bladder Cancer.
Ryu D; Kim TM; Lee YH; Ha US
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176124
[TBL] [Abstract][Full Text] [Related]
20. Genomic Alteration During Metastasis of Lung Adenocarcinoma.
Tan Q; Cui J; Huang J; Ding Z; Lin H; Niu X; Li Z; Wang G; Luo Q; Lu S
Cell Physiol Biochem; 2016; 38(2):469-86. PubMed ID: 26828653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
